Correcting CFTR mRNA splicing defects with the plant cytokine kinetin and its analogues
Journal of Cystic Fibrosis · 2026
DOI: 10.1016/j.jcf.2025.11.006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cystic Fibrosis, 2026. Verfasst von Valeria Rimoldi und 16 weiteren Autor:innen. Beteiligte Einrichtung: IRCCS Humanitas Research Hospital - via Manzoni 56, 20089 Rozzano, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Via Rita Le…. Hauptthemen laut MEDLINE: Cystic Fibrosis Transmembrane Conductance Regulator, Cystic Fibrosis, Kinetin, RNA Splicing. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Science for Life Laboratory, Uppsala Multidisciplinary Center for Advanced Computational Science, Cystic Fibrosis Research Foundation.
Abstract (Originalsprache)
BACKGROUND: Cystic Fibrosis (CF) results from CFTR gene mutations, including splicing defects such as the polymorphic TGnTm repeat, which disrupts exon-10 inclusion and contributes to CF monosymptomatic forms. While recent advances in CF treatment have led to targeted therapies for specific CFTR defects, most splicing variants remain without an effective treatment. Small molecules, like the plant cytokine kinetin, have shown promise in correcting splicing defects in other genetic diseases, offering potential for personalized CF therapies. METHODS: This study evaluated the efficacy of kinetin and its analogue, RECTAS, in correcting CFTR exon-10 splicing defects caused by TGnTm repeats. Cell models and patient-derived cells were treated with both compounds to assess their ability to enhance exon-10 inclusion. The impact of these treatments on splicing correction and CFTR protein expression was analyzed using molecular and cellular assays. RESULTS: Both kinetin and RECTAS improved exon-10 inclusion, with RECTAS demonstrating superior efficacy, achieving up to a four-fold increase in patient-derived cells compared to kinetin. Additionally, RECTAS consistently rescued exon-10 splicing across various TG-T alleles and successfully restored CFTR protein expression, highlighting its potential as a more potent therapeutic option. CONCLUSIONS: These findings identify RECTAS as an effective modulator of CFTR splicing. Rather than stand-alone therapeutics, kinetin and its analogues may act as transcript amplifiers, thereby possibly enhancing the efficacy of existing CFTR modulators. This approach could broaden treatment options for splicing-related CFTR variants and other genetic disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- IRCCS Humanitas Research Hospital - via Manzoni 56, 20089 Rozzano, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, 20090 Pieve Emanuele, Milan, Italy.
- IRCCS Humanitas Research Hospital - via Manzoni 56, 20089 Rozzano, Milan, Italy.
- Medical Genetics Laboratory, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy; Cystic Fibrosis Center of Milan, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
- UOC Genetica Medica, IRCCS Istituto Giannina Gaslini, 16148 Genova, Italy.
- Department of Biological, Chemical and Pharmaceutical Sciences and Technologies (STEBICEF), Viale delle Scienze ED.16, Parco d'Orleans 90128 Palermo.
- Department of Medical Biotechnology and Translational Medicine, University of Milano, Segrate, Milano, Italy.
Förderung
- Science for Life Laboratory
- Uppsala Multidisciplinary Center for Advanced Computational Science
- Cystic Fibrosis Research Foundation
- Fédération Française de Cardiologie
Zitieren
APA
Rimoldi, V., Soldà, G., Capalbo, A., Saba, E., Giannone, V., Capurro, V., Lentini, L., Melfi, R., Lazzeri, M., Porcaro, L., Seia, M., Aureli, M., Pedemonte, N., Duga, S., Orrenius, C., Asselta, R., & Straniero, L. (2026). Correcting CFTR mRNA splicing defects with the plant cytokine kinetin and its analogues. Journal of Cystic Fibrosis. https://doi.org/10.1016/j.jcf.2025.11.006
Vancouver
Rimoldi V, Soldà G, Capalbo A, Saba E, Giannone V, Capurro V, et al. Correcting CFTR mRNA splicing defects with the plant cytokine kinetin and its analogues. Journal of Cystic Fibrosis. 2026. doi:10.1016/j.jcf.2025.11.006
BibTeX
@article{Rimoldi2026,
author = {Rimoldi, Valeria and Soldà, Giulia and Capalbo, Anita and Saba, Elena and Giannone, Valentina and Capurro, Valeria and Lentini, Laura and Melfi, Raffaella and Lazzeri, Massimo and Porcaro, Luigi and Seia, Manuela and Aureli, Massimo and Pedemonte, Nicoletta and Duga, Stefano and Orrenius, Christian and Asselta, Rosanna and Straniero, Letizia},
title = {Correcting CFTR mRNA splicing defects with the plant cytokine kinetin and its analogues},
journal = {Journal of Cystic Fibrosis},
year = {2026},
doi = {10.1016/j.jcf.2025.11.006}
}
EUVIMED